SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA (1282)

Specialty: General Immunology


Welcome to the PulseAid listing for the SCIMEDX PHASE II ANTI-PR3 ANTIBODY EIA medical device. This device is used in the General Immunology healthcare specialty. Below, you can view the analytes this device is used to test, and its corresponding complexity (HIGH, MODERATE, or CLIA WAIVED). We have also randomly listed additional medical devices used in the General Immunology healthcare specialty at the bottom of the page.

Analytes Measured/Detected and Complexity:

ANALYTECOMPLEXITY
Anti-proteinase-3 (Pr-3) antibodies (K010287 | K010287) HIGH
Effective Date: 2001-03-28

Other General Immunology Devices:

Medical DeviceComplexity
Difco Latex Flocculation Test – TrichinosisView Complexity
Beckman Auto ICSView Complexity
SQI Diagnostics sqid-X systemView Complexity
Germaine Laboratories Febrile AntigensView Complexity
Becton Dickinson Macro-vue RFView Complexity
Luminex 100 Integrated SystemView Complexity
Beckman Synchron CX 5View Complexity
Coulter EPICS XL-MCLView Complexity
ROCHE DIAGNOSTICS COBAS BIOView Complexity
Diamedix Immunosimplicity (Is)-VZV IgGView Complexity